Press Releases

Monday, July 8, 2013

Cleveland BioLabs, Inc. (NASDAQ:CBLI), Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, and Roswell Park Cancer Institute (RPCI) today announced the publication of studies describing the Facilitates Chromatin Transcription (FACT) complex as an accelerator of tumor transformation and a potential marker and target for aggressive cancers in Cell Reports, a peer-reviewed journal.

Friday, June 28, 2013

A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma.

Thursday, June 27, 2013

The University of Rochester Medical Center and Roswell Park Cancer Institute (RPCI) have received accreditation from the Accreditation Council for Graduate Medical Education (ACGME) for a joint two-year fellowship program in complex general surgical oncology.

Wednesday, June 26, 2013

America’s biopharmaceutical research companies have conducted more than 7,000 clinical trials of new medicines in New York over the last 13 years, working in collaboration with academic institutions, patient advocates, hospitals and clinical research facilities.

Saturday, June 22, 2013

The Ride For Roswell, Roswell Park Cancer Institute’s largest fundraiser, welcomed more than 8,000 riders, who traveled on routes ranging from 3 to 100 miles today, each starting and ending at the University at Buffalo (UB), Amherst Campus.

Tuesday, June 11, 2013

Researchers at Roswell Park Cancer Institute (RPCI) have determined that cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CS/HIPEC), a complex procedure to treat advanced abdominal cancers, can be done safely, and may be an effective therapy for select patients. Study results are published in the June issue of Cancer Medicine.

Friday, May 31, 2013

A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute (RPCI) and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational pharmacological therapy that shows promise for treating both solid-tumor cancers and hematologic malignancies.

Tuesday, May 28, 2013

MINNEAPOLIS—May 28, 2013—Survival rates have increased significantly among patients who received blood stem cell transplants from both related and unrelated donors, according to a study published in the Journal of Clinical Oncology today.

Wednesday, May 22, 2013

BUFFALO, N.Y. – Local photographers are encouraged to submit photographic works of art for consideration in the Oseroff Memorial Photography Purchase Prize. The winning work of art will be purchased and donated to Roswell Park Cancer Institute’s (RPCI) permanent art collection. 

Thursday, May 9, 2013

BUFFALO, N.Y. — Roswell Park Cancer Institute (RPCI) and The Ride For Roswell are pleased to announce that former San Francisco Giants pitcher Dave Dravecky will share his inspirational message at The Ride For Roswell 2013 Opening Ceremony on Friday evening, June 21, 2013.

Thursday, May 2, 2013

BUFFALO, NY — Roswell Park Cancer Institute (RPCI) is proud to announce that several faculty members have received grant funding totaling more than $3.3 million from federal agencies and other sources.